2018

2018

2A Pharma in collaboration with partners from DTI & DNASense granted EUR 653.000 Eurostars funding for 2AP07
2020

2020

Phase 1 Clinical Trial of the AAVLP-HPV project completed
2019

2019

First volunteer in Phase 1 Clinical Trial of novel HPV L2 vaccine